Device Cardiology/Vascular Diseases

Solia

Payments companies reported to CMS as associated with Solia. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$458Kassociated payments (2023-2025)
510clinicians with associated payments
1company reporting

By year

2023 $194K
2024 $220K
2025 $44K

Payments reported as associated with Solia, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $336K
Cardiovascular Disease $60K
Internal Medicine $20K
Advanced Heart Failure and Transplant Cardiology $20K
Interventional Cardiology $5,377
Hospitalist $1,993

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Solia

These are the largest totals companies reported as associated with Solia. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Gaurav Upadhyay Chicago, IL Clinical Cardiac Electrophysiology $125,130.87
Gregory Harris Greenville, NC Clinical Cardiac Electrophysiology $24,179.53
Marrick Kukin New York, NY Cardiovascular Disease $15,115.00
James Heywood La Jolla, CA Advanced Heart Failure and Transplant Cardiology $12,400.00
Antonio Moretta Sarasota, FL Clinical Cardiac Electrophysiology $11,335.75
Matthew Levy San Jose, CA Clinical Cardiac Electrophysiology $11,132.87
Christopher Liu New York, NY Clinical Cardiac Electrophysiology $10,798.72
Karthik Venkatesh Prasad Tupelo, MS Clinical Cardiac Electrophysiology $10,486.15
Adheesh Agnihotri Clermont, FL Clinical Cardiac Electrophysiology $10,355.81
Thirupath Reddy San Jose, CA Internal Medicine $9,859.96

Prescribed Solia?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.